- RIMS names 2016 president
The Risk & Insurance Management Society Inc. announced Monday its new president for the 2016 term will be Julie Pemberton, with Outerwall Inc.
- Aspen Insurance taps rival firms for global product heads
Aspen Insurance, the insurance segment of Aspen Insurance Holdings Ltd., said Monday that it has appointed new global product heads.
- Higher interest rates helped keep large pension plans stable in 2015
The funded status of pension plans sponsored by large companies remained stable in 2015 as higher interest rates, which lower the value of plan liabilities, offset lackluster investment returns, according to a survey released Monday.
- Volkswagen penalties for environment violations could top $90 billion
(Reuters) — The U.S. Justice Department on Monday filed a civil lawsuit against Volkswagen A.G. for allegedly violating the Clean Air Act by installing illegal devices to impair emission control systems in nearly 600,000 vehicles.
- Opioid overdose deaths hit record in 2014
There were a record number of overdose deaths from opioids and heroin in the United States in 2014, the U.S. Centers for Disease Control and Prevention said.
- UPS driver gets comp for heavy-lifting injury, but negligence claim denied
A United Parcel Service Inc. delivery driver who received workers compensation for injuries caused by lifting a heavy box can’t pursue a negligence claim against the package’s sender, a California appellate court has ruled.
- Signups in fed health exchange up sharply over last year
More than 8.5 million individuals signed up for health insurance plans through the federal exchange during the first eight weeks of enrollment for 2016 coverage, the U.S. Centers for Medicare and Medicaid Services reported last week.
- Medical liability insurer acquires Florida medical malpractice provider
Norcal Mutual Insurance Co. said Monday that it has completed it’s acquisition of Jacksonville, Florida-based FD Insurance.
- FDA drug approvals at 19-year high amid industry challenges
(Reuters) — 2015 was a good year for innovation in medicine with the U.S. Food and Drug Administration approving 45 novel drugs, four more than in 2014 and the most since the all-time record of 53 set in 1996.